Immatics NV
NASDAQ:IMTX

Watchlist Manager
Immatics NV Logo
Immatics NV
NASDAQ:IMTX
Watchlist
Price: 4.52 USD -3.21% Market Closed
Market Cap: 549.4m USD

Wall Street
Price Targets

IMTX Price Targets Summary
Immatics NV

Wall Street analysts forecast IMTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMTX is 15.56 USD with a low forecast of 9.6 USD and a high forecast of 21 USD.

Lowest
Price Target
9.6 USD
112% Upside
Average
Price Target
15.56 USD
244% Upside
Highest
Price Target
21 USD
365% Upside
Immatics NV Competitors:
Price Targets
VRTX
Vertex Pharmaceuticals Inc
4% Upside
301080
Acrobiosystems Co Ltd
8% Upside
6955
Shandong Boan Biotechnology Co Ltd
2% Downside
096530
Seegene Inc
45% Upside
DVAX
Dynavax Technologies Corp
126% Upside
VIR
Vir Biotechnology Inc
460% Upside
RNA
Avidity Biosciences Inc
121% Upside
APGE
Apogee Therapeutics Inc
159% Upside

Revenue
Forecast

Revenue Estimate
Immatics NV

For the last 5 years the compound annual growth rate for Immatics NV's revenue is 53%. The projected CAGR for the next 3 years is -10%.

53%
Past Growth
-10%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Immatics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Immatics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMTX's stock price target?
Price Target
15.56 USD

According to Wall Street analysts, the average 1-year price target for IMTX is 15.56 USD with a low forecast of 9.6 USD and a high forecast of 21 USD.

What is Immatics NV's Revenue forecast?
Projected CAGR
-10%

For the last 5 years the compound annual growth rate for Immatics NV's revenue is 53%. The projected CAGR for the next 3 years is -10%.

Back to Top